$Moderna, Inc.(MRNA)$$Pfizer(PFE)$Am I missing something in my evaluation? For the same situation, why is Moderna’s increase more than 25% while Pfizer’s increase is less than 8%? Especially if you take into account that Pfizer is actually the preferred vaccine and also came out with response time of approximately 100 days to evaluate and tweak to the new variant. Plus it is also appearing to be the better oral meds (with Merck fairing only 30%).

$Pfizer(PFE)$There is no logic to this when we consider how in relation to covid only, (a) revenue from vaccines are increasing with recent fda approvals for booster shots, revenue from vaccines once trial for children-use is completed, and (c) most importantly, new revenue stream from oral medication.  Further streams are also coming in from non-covid related medications approved recently.